Pearl River Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,637
| Closed | -$294K | – | 497 |
|
|
2022
Q4 | $294K | Buy |
25,637
+5,114
| +25% | +$58.7K | 0.05% | 417 |
|
|
2022
Q3 | $259K | Buy |
+20,523
| New | +$259K | 0.05% | 398 |
|
|
2022
Q2 | – | Sell |
-45,155
| Closed | -$734K | – | 442 |
|
|
2022
Q1 | $734K | Buy |
45,155
+11,275
| +33% | +$183K | 0.2% | 156 |
|
|
2021
Q4 | $469K | Buy |
33,880
+4,390
| +15% | +$60.8K | 0.13% | 230 |
|
|
2021
Q3 | $424K | Sell |
29,490
-30,939
| -51% | -$445K | 0.12% | 251 |
|
|
2021
Q2 | $955K | Buy |
+60,429
| New | +$955K | 0.26% | 119 |
|
|
2020
Q1 | – | Sell |
-10,989
| Closed | -$38K | – | 514 |
|
|
2019
Q4 | $38K | Buy |
+10,989
| New | +$38K | 0.01% | 509 |
|